Related Experiment Video
Updated: Jan 14, 2026

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
Published on: October 18, 2022
Investigating the molecular mechanisms underlying the anti-CRISPR function of AcrIIA13b protein
So Yeon Lee1,2, Hyun Ho Park1,2
1College of Pharmacy, Chung-Ang University, Seoul, Korea.
Abstract:
The CRISPR-Cas systems of adaptive immunity in bacteria and archaea provide resistance against phages and other mobile genetic elements. Counteractive anti-CRISPR (Acr) proteins in phages and archaeal viruses impede these CRISPR-Cas systems. Although CRISPR-Cas systems have revolutionized genome editing, potential off-target events remain a safety concern. Hence, a thorough comprehension of the structural and molecular basis of diverse Acrs is imperative to unravel the fundamental mechanisms governing CRISPR-Cas regulation. Here, we present the structure of AcrIIA13b from Staphylococcus haemolyticus and analyze its structural and functional features to reveal the molecular basis underlying the inhibition of Cas9 by AcrIIA13b. Our structural analysis shows that AcrIIA13b eliminates the cleavage activity of Staphylococcus aureus Cas9 (SauCas9) by blocking the PAM-binding region of Cas9 so that Cas9 cannot recognize the target DNA. In addition, we demonstrate that the 15 amino acid residues at the N terminus of AcrIIA13b, which were revealed to be important for its dimerization, are critical for its inhibitory activity against Cas9. Our findings shed light on the molecular basis of AcrIIA13b-mediated CRISPR-Cas inhibition and provide valuable insights into the arms race between bacteria and phages.
Insights
Researchers uncovered how anti-CRISPR protein AcrIIA13b inhibits Staphylococcus aureus Cas9 (SauCas9) by blocking DNA binding. This discovery deepens our understanding of CRISPR-Cas regulation and phage-bacteria interactions.
Area of Science:
- Molecular Biology
- Genetics
- Microbiology
Background:
- CRISPR-Cas systems provide bacterial and archaeal immunity against mobile genetic elements.
- Anti-CRISPR (Acr) proteins from phages and viruses counteract CRISPR-Cas systems.
- Understanding Acrs is crucial for improving CRISPR-Cas genome editing safety and efficacy.
Purpose of the Study:
- To elucidate the structural and molecular mechanisms by which AcrIIA13b inhibits Staphylococcus aureus Cas9 (SauCas9).
- To provide insights into the regulation of CRISPR-Cas systems and the evolutionary arms race between phages and bacteria.
Main Methods:
- X-ray crystallography to determine the structure of AcrIIA13b.
- Biochemical assays to analyze the functional features and inhibitory activity of AcrIIA13b against SauCas9.
- Site-directed mutagenesis to investigate the role of N-terminal amino acid residues.
Main Results:
- The structure of AcrIIA13b was determined, revealing its interaction with SauCas9.
- AcrIIA13b inhibits SauCas9 by blocking the Protospacer Adjacent Motif (PAM)-binding region, preventing target DNA recognition.
- The N-terminal 15 amino acids of AcrIIA13b are critical for its dimerization and inhibitory function.
Conclusions:
- AcrIIA13b effectively inhibits SauCas9 by sterically hindering PAM recognition.
- The N-terminal dimerization domain of AcrIIA13b is essential for its anti-CRISPR activity.
- These findings enhance comprehension of CRISPR-Cas inhibition mechanisms and phage-host interactions.
Related Concept Videos
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The Antiviral System of Bacteria and Archaea: CRISPR
CRISPR
CRISPR/Cas9 Genome Editing
Experimental RNAi
Caspases

